BACKGROUND: The dose of mifepristone approved by most government agencies for
medical abortion is 600 mg. Our aim was to summarize extant data on the effectiveness and …

OBJECTIVE: To compare medical abortion practised at home and in clinics in terms of
effectiveness, safety and acceptability. METHODS: A systematic search for randomized …

Background Medical abortion is under-used in developing countries. We assessed whether
early first-trimester medical abortion provided by midlevel providers (government-trained …

Unsafe abortion's significant contribution to maternal mortality and morbidity was a critical
factor leading to liberalization of Nepal's restrictive abortion law in 2002. Careful …

Background Increased access to home-based medical abortion may offer women a
convenient, safe and effective abortion method, reduce burdens on healthcare systems and …

Background The advent of medical abortion has improved access to safe abortion
procedures. Medical abortion procedures involve either administering mifepristone followed …

Objective To investigate abortion practices of N epali women requiring postabortion care.
Design Cross‐sectional study. Setting Four tertiary‐care hospitals in urban and rural N epal …

BACKGROUND: Most medical abortion protocols require women to take mifepristone in the
doctor's office. We assessed the acceptability of home use of mifepristone among women …

Introduction The administration of mifepristone, followed by misoprostol, is widely used for
medical abortion. Many studies have demonstrated home abortion to be safe in pregnancies …

Objective This study aimed to assess women´ s acceptability of diagnosis and treatment of
incomplete abortion with misoprostol by midwives, compared with physicians. Methods This …